Aardvark Therapeutics Inc (AARD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 61,641 | 0 | 0 | 0 | 9,735 |
| Marketable Securities | 12,022 | 0 | 0 | 0 | 254 |
| Other current assets | 0 | 0 | 0 | 0 | 379 |
| TOTAL | $74,137 | $0 | $0 | $0 | $10,368 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 3,370 | 0 | 0 | 0 | 13 |
| TOTAL | $3,370 | $N/A | $N/A | $N/A | $13 |
| Total Assets | $77,507 | $0 | $0 | $0 | $10,536 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,298 | 0 | 0 | 0 | 1,035 |
| Accrued Expenses | 2,291 | 0 | 0 | 0 | 235 |
| TOTAL | $4,927 | $0 | $0 | $0 | $1,382 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 467 | 0 | 0 | 0 | 2 |
| TOTAL | $467 | $N/A | $N/A | $N/A | $2 |
| Total Liabilities | $5,394 | $0 | $0 | $0 | $1,434 |
| Shareholders' Equity | |||||
| Retained earnings | -58,327 | 0 | 0 | 0 | -37,739 |
| Other shareholders' equity | 126,756 | 0 | 0 | 0 | 43,904 |
| TOTAL | $72,113 | $0 | $0 | $0 | $9,102 |
| Total Liabilities And Equity | $77,507 | $0 | $0 | $0 | $10,536 |